Quercetin and Quercitrin from Agrimonia pilosa Ledeb Inhibit the Migration and Invasion of Colon Cancer Cells through the JNK Signaling Pathway
Open Access
- 17 March 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (3) , 364
Abstract
Considering the high metastatic potential of colorectal cancer (CRC), the inhibition of metastasis is important for anti-CRC therapy. Agrimonia pilosa Ledeb (A. pilosa) is a perennial herbaceous plant that is widely distributed in Asia. The extracts of A. pilosa have shown diverse pharmacological properties, such as antimicrobial, anti-inflammatory, and antitumor activities. In the present study, the antimetastatic activity of A. pilosa was evaluated. Methanol extraction from the roots of A. pilosa was performed by high-performance liquid chromatography (HPLC) and 12 fractions were obtained. Among these, fraction 4 showed the most potent inhibitory effect on the migration of colon cancer cells. Using LC-HR MS analysis, quercetin and quercitrin were identified as flavonoids contained in fraction 4. Like fraction 4, quercetin and quercitrin effectively inhibited the migration and invasion of RKO cells. While the level of E-cadherin was increased, the levels of N-cadherin and vimentin were decreased by the same agents. Although they all activate the p38, JNK, and ERK signaling pathways, only SP600125, an inhibitor of the JNK pathway, specifically inhibited the effect of fraction 4, quercetin, and quercitrin on cell migration. An in vivo experiment also confirmed the antitumor activity of quercetin and quercitrin. Collectively, these results suggest that A. pilosa and its two flavonoids, quercetin and quercitrin, are candidates for the antimetastatic treatment of CRC.Keywords
Funding Information
- Korea Government (MSIT) (2020R1F1A1071179)
This publication has 32 references indexed in Scilit:
- Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?Current Medicinal Chemistry, 2015
- Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiationPharmacology & Therapeutics, 2015
- Molecular Mechanisms of Quercitrin-induced Apoptosis in Non-small Cell Lung CancerArchives of Medical Research, 2014
- Colorectal cancerThe Lancet, 2014
- Cancer treatment and survivorship statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Quercetin inhibition of tumor invasion via suppressing PKC /ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cellsCarcinogenesis, 2008
- EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancerFrontiers in Bioscience-Landmark, 2008
- Antitumor Activity of Novel Indirubin Derivatives in Rat Tumor ModelClinical Cancer Research, 2007
- Antihyperglycemic Activity of Herb Extracts on Streptozotocin-Induced Diabetic RatsBioscience, Biotechnology, and Biochemistry, 2006